TipRanks
Go Ultimate55% OFF

Cytosorbents (HQE) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

HQE Analyst Ratings

Moderate Buy
2Ratings
1Buy1Hold0Sell
Based on 2 analysts giving stock ratings to Cytosorbents in the past 3 months

HQE Stock 12 Month Forecast

EUR 10.90▲(101.81% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Cytosorbents in the last 3 months. The average price target is EUR 10.90 with a high forecast of EUR 13.34 and a low forecast of EUR 8.45. The average price target represents a 101.81% change from the last price of EUR 5.40.
Highest Price TargetEUR 13.34Average Price TargetEUR 10.90Lowest Price TargetEUR 8.45

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for DE:HQE
Price TargetFollowArticle
WBB SecuritiesEUR 8.45buy56.51%UpsideInitiated10/21/26
H.C. WainwrightEUR 13.34hold147.12%UpsideReiterated08/07/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AXGNAxoGen
SLDBSolid Biosciences
AHCOAdaptHealth
ONCBeOne Medicines
ARDXArdelyx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cytosorbents

3 Months
Anthropic Medical - Devices
Anthropic Medical - DevicesTipRanks - Anthropic
Success Rate1/1 ratings generated profit
100%
Average Return
+33.90%

Copying Anthropic Medical - Devices's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +33.90% per trade.

1 Year
Anthropic Medical - Devices
Anthropic Medical - DevicesTipRanks - Anthropic
Success Rate1/1 ratings generated profit
100%
Average Return
+59.90%

Copying Anthropic Medical - Devices's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +59.90% per trade.

2 Years
Anthropic Medical - Devices
Anthropic Medical - DevicesTipRanks - Anthropic
Success Rate1/1 ratings generated profit
100%
Average Return
+59.90%

Copying Anthropic Medical - Devices's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +59.90% per trade.

HQE Analyst Recommendation Trends

01234Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for HQE
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00022
Buy00000
Hold11110
Sell00000
Strong Sell00000
total11132

In the current month, HQE has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. HQE average Analyst price target in the past 3 months is 10.90.

HQE Financial Forecast

EUR -3EUR -2.25EUR -1.5EUR -0.75EUR 0Q4 2025Q2 2026Q3 2026
HighEUR -0.71
ConsensusEUR -0.80
LowEUR -0.89

HQE Earnings Forecast

Next quarter’s earnings estimate for HQE is -EUR 0.80 with a range of -EUR 0.89 to -EUR 0.71. The previous quarter’s EPS was -EUR 1.24. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

EUR 7.9MEUR 8.2MEUR 8.4MEUR 8.7MEUR 9MQ4 2025Q2 2026Q3 2026
HighEUR 8.97M
ConsensusEUR 8.8M
LowEUR 8.62M

HQE Sales Forecast

Next quarter’s sales forecast for HQE is EUR 8.80M with a range of EUR 8.62M to EUR 8.97M. The previous quarter’s sales results were EUR 8.56M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

HQE Stock Forecast FAQ

What is DE:HQE’s average 12-month price target, according to analysts?
Based on analyst ratings, Cytosorbents’s 12-month average price target is €10.90.
What is DE:HQE’s upside potential, based on the analysts’ average price target?
Cytosorbents has 101.81% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Cytosorbents a Buy, Sell or Hold?
Cytosorbents has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
What is Cytosorbents’s share price target?
The average share price target for Cytosorbents is €10.90. This is based on 2 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €13.34, and the lowest forecast is €8.45. The average share price target represents a 101.81% increase from the current price of €5.4.
What do analysts say about Cytosorbents?
Cytosorbents’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of Cytosorbents?
To buy shares of DE:HQE, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.